img

Global Neuromuscular Blocking Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Neuromuscular Blocking Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Neuromuscular blocking drugs cause paralysis of the affected skeletal muscles by blocking neuromuscular transmission at the neuromuscular junction.
Neuromuscular Blocking Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neuromuscular Blocking Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Neuromuscular Blocking Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Neuromuscular Blocking Drug key manufacturers include Hikma Pharmaceuticals, Merck, Novartis, Bayer, Pfizer, AbbVie and GSK, etc. Hikma Pharmaceuticals, Merck, Novartis are top 3 players and held % sales share in total in 2022.
Neuromuscular Blocking Drug can be divided into Non-polarizing Agents and Depolarizing Agents, etc. Non-polarizing Agents is the mainstream product in the market, accounting for % sales share globally in 2022.
Neuromuscular Blocking Drug is widely used in various fields, such as Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others, etc. Hospital Pharmacy provides greatest supports to the Neuromuscular Blocking Drug industry development. In 2022, global % sales of Neuromuscular Blocking Drug went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neuromuscular Blocking Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Hikma Pharmaceuticals
Merck
Novartis
Bayer
Pfizer
AbbVie
GSK
Segment by Type
Non-polarizing Agents
Depolarizing Agents

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neuromuscular Blocking Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Neuromuscular Blocking Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Neuromuscular Blocking Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Neuromuscular Blocking Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Neuromuscular Blocking Drug introduction, etc. Neuromuscular Blocking Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Neuromuscular Blocking Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Neuromuscular Blocking Drug Market Overview
1.1 Neuromuscular Blocking Drug Product Overview
1.2 Neuromuscular Blocking Drug Market Segment by Type
1.2.1 Non-polarizing Agents
1.2.2 Depolarizing Agents
1.3 Global Neuromuscular Blocking Drug Market Size by Type
1.3.1 Global Neuromuscular Blocking Drug Market Size Overview by Type (2024-2034)
1.3.2 Global Neuromuscular Blocking Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global Neuromuscular Blocking Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Neuromuscular Blocking Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe Neuromuscular Blocking Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Neuromuscular Blocking Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Neuromuscular Blocking Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Neuromuscular Blocking Drug Sales Breakdown by Type (2024-2024)
2 Global Neuromuscular Blocking Drug Market Competition by Company
2.1 Global Top Players by Neuromuscular Blocking Drug Sales (2024-2024)
2.2 Global Top Players by Neuromuscular Blocking Drug Revenue (2024-2024)
2.3 Global Top Players by Neuromuscular Blocking Drug Price (2024-2024)
2.4 Global Top Manufacturers Neuromuscular Blocking Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Neuromuscular Blocking Drug Market Competitive Situation and Trends
2.5.1 Neuromuscular Blocking Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Neuromuscular Blocking Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuromuscular Blocking Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Neuromuscular Blocking Drug Market
2.8 Key Manufacturers Neuromuscular Blocking Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Neuromuscular Blocking Drug Status and Outlook by Region
3.1 Global Neuromuscular Blocking Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Neuromuscular Blocking Drug Historic Market Size by Region
3.2.1 Global Neuromuscular Blocking Drug Sales in Volume by Region (2024-2024)
3.2.2 Global Neuromuscular Blocking Drug Sales in Value by Region (2024-2024)
3.2.3 Global Neuromuscular Blocking Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Neuromuscular Blocking Drug Forecasted Market Size by Region
3.3.1 Global Neuromuscular Blocking Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Neuromuscular Blocking Drug Sales in Value by Region (2024-2034)
3.3.3 Global Neuromuscular Blocking Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Neuromuscular Blocking Drug by Application
4.1 Neuromuscular Blocking Drug Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.1.4 Others
4.2 Global Neuromuscular Blocking Drug Market Size by Application
4.2.1 Global Neuromuscular Blocking Drug Market Size Overview by Application (2024-2034)
4.2.2 Global Neuromuscular Blocking Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global Neuromuscular Blocking Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Neuromuscular Blocking Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe Neuromuscular Blocking Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Neuromuscular Blocking Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Neuromuscular Blocking Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Neuromuscular Blocking Drug Sales Breakdown by Application (2024-2024)
5 North America Neuromuscular Blocking Drug by Country
5.1 North America Neuromuscular Blocking Drug Historic Market Size by Country
5.1.1 North America Neuromuscular Blocking Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Neuromuscular Blocking Drug Sales in Volume by Country (2024-2024)
5.1.3 North America Neuromuscular Blocking Drug Sales in Value by Country (2024-2024)
5.2 North America Neuromuscular Blocking Drug Forecasted Market Size by Country
5.2.1 North America Neuromuscular Blocking Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Neuromuscular Blocking Drug Sales in Value by Country (2024-2034)
6 Europe Neuromuscular Blocking Drug by Country
6.1 Europe Neuromuscular Blocking Drug Historic Market Size by Country
6.1.1 Europe Neuromuscular Blocking Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Neuromuscular Blocking Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe Neuromuscular Blocking Drug Sales in Value by Country (2024-2024)
6.2 Europe Neuromuscular Blocking Drug Forecasted Market Size by Country
6.2.1 Europe Neuromuscular Blocking Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Neuromuscular Blocking Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Neuromuscular Blocking Drug by Region
7.1 Asia-Pacific Neuromuscular Blocking Drug Historic Market Size by Region
7.1.1 Asia-Pacific Neuromuscular Blocking Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Neuromuscular Blocking Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Neuromuscular Blocking Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Neuromuscular Blocking Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Neuromuscular Blocking Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Neuromuscular Blocking Drug Sales in Value by Region (2024-2034)
8 Latin America Neuromuscular Blocking Drug by Country
8.1 Latin America Neuromuscular Blocking Drug Historic Market Size by Country
8.1.1 Latin America Neuromuscular Blocking Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Neuromuscular Blocking Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America Neuromuscular Blocking Drug Sales in Value by Country (2024-2024)
8.2 Latin America Neuromuscular Blocking Drug Forecasted Market Size by Country
8.2.1 Latin America Neuromuscular Blocking Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Neuromuscular Blocking Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Neuromuscular Blocking Drug by Country
9.1 Middle East and Africa Neuromuscular Blocking Drug Historic Market Size by Country
9.1.1 Middle East and Africa Neuromuscular Blocking Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Neuromuscular Blocking Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Neuromuscular Blocking Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Neuromuscular Blocking Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Neuromuscular Blocking Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Neuromuscular Blocking Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Hikma Pharmaceuticals
10.1.1 Hikma Pharmaceuticals Company Information
10.1.2 Hikma Pharmaceuticals Introduction and Business Overview
10.1.3 Hikma Pharmaceuticals Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Hikma Pharmaceuticals Neuromuscular Blocking Drug Products Offered
10.1.5 Hikma Pharmaceuticals Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck Neuromuscular Blocking Drug Products Offered
10.2.5 Merck Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Novartis Neuromuscular Blocking Drug Products Offered
10.3.5 Novartis Recent Development
10.4 Bayer
10.4.1 Bayer Company Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Bayer Neuromuscular Blocking Drug Products Offered
10.4.5 Bayer Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Pfizer Neuromuscular Blocking Drug Products Offered
10.5.5 Pfizer Recent Development
10.6 AbbVie
10.6.1 AbbVie Company Information
10.6.2 AbbVie Introduction and Business Overview
10.6.3 AbbVie Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 AbbVie Neuromuscular Blocking Drug Products Offered
10.6.5 AbbVie Recent Development
10.7 GSK
10.7.1 GSK Company Information
10.7.2 GSK Introduction and Business Overview
10.7.3 GSK Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2024-2024)
10.7.4 GSK Neuromuscular Blocking Drug Products Offered
10.7.5 GSK Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Neuromuscular Blocking Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Neuromuscular Blocking Drug Industrial Chain Analysis
11.4 Neuromuscular Blocking Drug Market Dynamics
11.4.1 Neuromuscular Blocking Drug Industry Trends
11.4.2 Neuromuscular Blocking Drug Market Drivers
11.4.3 Neuromuscular Blocking Drug Market Challenges
11.4.4 Neuromuscular Blocking Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Neuromuscular Blocking Drug Distributors
12.3 Neuromuscular Blocking Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Non-polarizing Agents
Table 2. Major Company of Depolarizing Agents
Table 3. Global Neuromuscular Blocking Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Neuromuscular Blocking Drug Sales by Type (2024-2024) & (K Units)
Table 5. Global Neuromuscular Blocking Drug Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Neuromuscular Blocking Drug Sales by Type (2024-2024) & (US& Million)
Table 7. Global Neuromuscular Blocking Drug Market Share in Value by Type (2024-2024)
Table 8. Global Neuromuscular Blocking Drug Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Neuromuscular Blocking Drug Sales by Type (2024-2034) & (K Units)
Table 10. Global Neuromuscular Blocking Drug Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Neuromuscular Blocking Drug Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Neuromuscular Blocking Drug Sales Market Share in Value by Type (2024-2034)
Table 13. Global Neuromuscular Blocking Drug Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Neuromuscular Blocking Drug Sales by Type (2024-2024) & (K Units)
Table 15. North America Neuromuscular Blocking Drug Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Neuromuscular Blocking Drug Sales (K Units) by Type (2024-2024)
Table 17. Europe Neuromuscular Blocking Drug Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Neuromuscular Blocking Drug Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Neuromuscular Blocking Drug Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Neuromuscular Blocking Drug Sales (K Units) by Type (2024-2024)
Table 21. Latin America Neuromuscular Blocking Drug Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Neuromuscular Blocking Drug Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Neuromuscular Blocking Drug Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Neuromuscular Blocking Drug Sales by Company (2024-2024) & (K Units)
Table 25. Global Neuromuscular Blocking Drug Sales Share by Company (2024-2024)
Table 26. Global Neuromuscular Blocking Drug Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Neuromuscular Blocking Drug Revenue Share by Company (2024-2024)
Table 28. Global Market Neuromuscular Blocking Drug Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Neuromuscular Blocking Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Neuromuscular Blocking Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuromuscular Blocking Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Neuromuscular Blocking Drug Market
Table 33. Key Manufacturers Neuromuscular Blocking Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Neuromuscular Blocking Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Neuromuscular Blocking Drug Sales by Region (2024-2024) & (K Units)
Table 37. Global Neuromuscular Blocking Drug Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Neuromuscular Blocking Drug Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Neuromuscular Blocking Drug Sales Market Share in Value by Region (2024-2024)
Table 40. Global Neuromuscular Blocking Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Neuromuscular Blocking Drug Sales by Region (2024-2034) & (K Units)
Table 42. Global Neuromuscular Blocking Drug Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Neuromuscular Blocking Drug Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Neuromuscular Blocking Drug Sales Market Share in Value by Region (2024-2034)
Table 45. Global Neuromuscular Blocking Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Neuromuscular Blocking Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Neuromuscular Blocking Drug Sales by Application (2024-2024) & (K Units)
Table 48. Global Neuromuscular Blocking Drug Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Neuromuscular Blocking Drug Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Neuromuscular Blocking Drug Sales Market Share in Value by Application (2024-2024)
Table 51. Global Neuromuscular Blocking Drug Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Neuromuscular Blocking Drug Sales by Application (2024-2034) & (K Units)
Table 53. Global Neuromuscular Blocking Drug Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Neuromuscular Blocking Drug Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Neuromuscular Blocking Drug Sales Market Share in Value by Application (2024-2034)
Table 56. Global Neuromuscular Blocking Drug Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Neuromuscular Blocking Drug Sales by Application (2024-2024) (K Units)
Table 58. North America Neuromuscular Blocking Drug Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Neuromuscular Blocking Drug Sales by Application (2024-2024) (K Units)
Table 60. Europe Neuromuscular Blocking Drug Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Neuromuscular Blocking Drug Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Neuromuscular Blocking Drug Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Neuromuscular Blocking Drug Sales by Application (2024-2024) (K Units)
Table 64. Latin America Neuromuscular Blocking Drug Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Neuromuscular Blocking Drug Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Neuromuscular Blocking Drug Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Neuromuscular Blocking Drug Sales by Country (2024-2024) & (K Units)
Table 68. North America Neuromuscular Blocking Drug Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Neuromuscular Blocking Drug Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Neuromuscular Blocking Drug Sales Market Share in Value by Country (2024-2024)
Table 71. North America Neuromuscular Blocking Drug Sales by Country (2024-2034) & (K Units)
Table 72. North America Neuromuscular Blocking Drug Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Neuromuscular Blocking Drug Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Neuromuscular Blocking Drug Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Neuromuscular Blocking Drug Sales by Country (2024-2024) & (K Units)
Table 76. Europe Neuromuscular Blocking Drug Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Neuromuscular Blocking Drug Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Neuromuscular Blocking Drug Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Neuromuscular Blocking Drug Sales by Country (2024-2034) & (K Units)
Table 80. Europe Neuromuscular Blocking Drug Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Neuromuscular Blocking Drug Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Neuromuscular Blocking Drug Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Neuromuscular Blocking Drug Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Neuromuscular Blocking Drug Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Neuromuscular Blocking Drug Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Neuromuscular Blocking Drug Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Neuromuscular Blocking Drug Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Neuromuscular Blocking Drug Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Neuromuscular Blocking Drug Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Neuromuscular Blocking Drug Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Neuromuscular Blocking Drug Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Neuromuscular Blocking Drug Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Neuromuscular Blocking Drug Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Neuromuscular Blocking Drug Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Neuromuscular Blocking Drug Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Neuromuscular Blocking Drug Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Neuromuscular Blocking Drug Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Neuromuscular Blocking Drug Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Neuromuscular Blocking Drug Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Neuromuscular Blocking Drug Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Neuromuscular Blocking Drug Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Neuromuscular Blocking Drug Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Neuromuscular Blocking Drug Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Neuromuscular Blocking Drug Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Neuromuscular Blocking Drug Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Neuromuscular Blocking Drug Sales Market Share in Value by Country (2024-2034)
Table 107. Hikma Pharmaceuticals Company Information
Table 108. Hikma Pharmaceuticals Introduction and Business Overview
Table 109. Hikma Pharmaceuticals Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Hikma Pharmaceuticals Neuromuscular Blocking Drug Product
Table 111. Hikma Pharmaceuticals Recent Development
Table 112. Merck Company Information
Table 113. Merck Introduction and Business Overview
Table 114. Merck Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Merck Neuromuscular Blocking Drug Product
Table 116. Merck Recent Development
Table 117. Novartis Company Information
Table 118. Novartis Introduction and Business Overview
Table 119. Novartis Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Novartis Neuromuscular Blocking Drug Product
Table 121. Novartis Recent Development
Table 122. Bayer Company Information
Table 123. Bayer Introduction and Business Overview
Table 124. Bayer Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Bayer Neuromuscular Blocking Drug Product
Table 126. Bayer Recent Development
Table 127. Pfizer Company Information
Table 128. Pfizer Introduction and Business Overview
Table 129. Pfizer Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Pfizer Neuromuscular Blocking Drug Product
Table 131. Pfizer Recent Development
Table 132. AbbVie Company Information
Table 133. AbbVie Introduction and Business Overview
Table 134. AbbVie Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. AbbVie Neuromuscular Blocking Drug Product
Table 136. AbbVie Recent Development
Table 137. GSK Company Information
Table 138. GSK Introduction and Business Overview
Table 139. GSK Neuromuscular Blocking Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. GSK Neuromuscular Blocking Drug Product
Table 141. GSK Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Neuromuscular Blocking Drug Market Trends
Table 145. Neuromuscular Blocking Drug Market Drivers
Table 146. Neuromuscular Blocking Drug Market Challenges
Table 147. Neuromuscular Blocking Drug Market Restraints
Table 148. Neuromuscular Blocking Drug Distributors List
Table 149. Neuromuscular Blocking Drug Downstream Customers
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuromuscular Blocking Drug Product Picture
Figure 2. Global Neuromuscular Blocking Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Neuromuscular Blocking Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Neuromuscular Blocking Drug Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Non-polarizing Agents
Figure 6. Global Non-polarizing Agents Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Depolarizing Agents
Figure 8. Global Depolarizing Agents Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Neuromuscular Blocking Drug Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Neuromuscular Blocking Drug Sales Market Share by Type in 2022 & 2034
Figure 11. North America Neuromuscular Blocking Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Neuromuscular Blocking Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Neuromuscular Blocking Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Neuromuscular Blocking Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Neuromuscular Blocking Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Neuromuscular Blocking Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Neuromuscular Blocking Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Neuromuscular Blocking Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Neuromuscular Blocking Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Neuromuscular Blocking Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Neuromuscular Blocking Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Neuromuscular Blocking Drug Revenue in 2022
Figure 23. Neuromuscular Blocking Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital Pharmacy
Figure 25. Global Hospital Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Retail Pharmacy
Figure 27. Global Retail Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Online Pharmacy
Figure 29. Global Online Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Global Neuromuscular Blocking Drug Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Neuromuscular Blocking Drug Sales Market Share by Application in 2022 & 2034
Figure 34. North America Neuromuscular Blocking Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Neuromuscular Blocking Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Neuromuscular Blocking Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Neuromuscular Blocking Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Neuromuscular Blocking Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Neuromuscular Blocking Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Neuromuscular Blocking Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Neuromuscular Blocking Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Neuromuscular Blocking Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Neuromuscular Blocking Drug Manufacturing Cost Structure
Figure 45. Neuromuscular Blocking Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries